{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:30:30Z","timestamp":1786437030080,"version":"build-2736575974"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Crohn disease (CD) and pregnancy often impact each other, which poses challenges for women with CD to successfully give birth to a healthy baby. The latest guideline recommends that patients with active inflammatory bowel disease delay pregnancy to induce remission and optimize disease control. Research data has showed that the incidence of infection and severe infection in patients treated with ustekinumab (UST) did not increase compared to those treated with a placebo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>This report describes the entire process of a pregnant woman with CD who has undergone ileostomy and long-term enteral nutrition and requires biological agents to control the disease, from conception to delivery. This case was pregnant during CD period and regularly treated with UST to the third trimester, with the onset of sepsis and septic shock at 38 weeks gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>The patient was pathologically diagnosed with CD 16 years ago and admitted to our department at 38 weeks gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>After admission to our department, fetal heart monitoring indicated fetal distress, so we immediately terminated the pregnancy by cesarean section. After the diagnosis of septic shock, the patient was transferred to intensive care unit for active anti-infection and symptomatic supportive treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The mother only experienced an infection in the third trimester, and cured by active treatment. The newborn was delivered at full term and confirmed to be low birth weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Her experience suggests that although pregnant during Crohn active period, a good outcome can be achieved through positively controlling with medication and closely monitoring it. The use of UST during pregnancy appears to be safe for both the mother and fetus but may be associated with severe infections.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000036253","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T22:05:56Z","timestamp":1701468356000},"page":"e36253","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Case report: A pregnant woman with Crohn disease who used ustekinumab to the 3rd trimester developed severe infection"],"prefix":"10.1097","volume":"102","author":[{"given":"Peng","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Zhongshan City People\u2019s Hospital, Zhongshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8202-7167","authenticated-orcid":false,"given":"Wulan","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Zhongshan City People\u2019s Hospital, Zhongshan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260811","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","article-title":"Epidemiology and natural history of inflammatory bowel diseases.","volume":"140","author":"Cosnes","year":"2011","journal-title":"Gastroenterology"},{"key":"R2-20260811","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/apt.13354","article-title":"Decreased fertility rates in 9639 women diagnosed with inflammatory bowel disease: a United Kingdom population-based cohort study.","volume":"42","author":"Ban","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"R3-20260811","first-page":"1091","article-title":"Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure.","volume":"20","author":"Broms","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"R4-20260811","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jss.2014.03.028","article-title":"The impact of pregnancy on surgical Crohn disease: an analysis of the Nationwide Inpatient Sample.","volume":"190","author":"Hatch","year":"2014","journal-title":"J Surg Res"},{"key":"R5-20260811","doi-asserted-by":"crossref","first-page":"200","DOI":"10.5217\/ir.2019.00103","article-title":"Risk factors associated with impaired ovarian reserve in young women of reproductive age with Crohn\u2019s disease.","volume":"18","author":"Zhao","year":"2020","journal-title":"Intest Res"},{"key":"R6-20260811","first-page":"579","article-title":"Inflammatory bowel disease and pregnancy: fertility, complications and treatment.","volume":"33","author":"Ali","year":"2020","journal-title":"Ann Gastroenterol"},{"key":"R7-20260811","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0020-7292(97)00088-X","article-title":"Fertility and pregnancy in inflammatory bowel disease.","volume":"58","author":"Hudson","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20260811","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.gtc.2011.03.006","article-title":"Inflammatory bowel disease in pregnancy.","volume":"40","author":"Beaulieu","year":"2011","journal-title":"Gastroenterol Clin North Am"},{"key":"R9-20260811","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2036.2007.03397.x","article-title":"Review article: reproduction in the patient with inflammatory bowel disease.","volume":"26","author":"Heetun","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R10-20260811","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/gutjnl-2022-329304","article-title":"Australian inflammatory bowel disease consensus statements for preconception, pregnancy and breast feeding.","volume":"72","author":"Laube","year":"2023","journal-title":"Gut"},{"key":"R11-20260811","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1007\/s10620-016-4353-5","article-title":"Long-term disease course and pregnancy outcomes in women with inflammatory bowel disease: an Indian cohort study.","volume":"62","author":"Padhan","year":"2017","journal-title":"Dig Dis Sci"},{"key":"R12-20260811","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1155\/2014\/967598","article-title":"Management of the pregnant inflammatory bowel disease patient on anti-tumour necrosis factor: state of the art and future directions.","volume":"28","author":"Leung","year":"2014","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R13-20260811","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/14767050410001668662","article-title":"Perinatal outcomes in inflammatory bowel disease.","volume":"15","author":"Bush","year":"2004","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R14-20260811","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2036.2011.04967.x","article-title":"Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.","volume":"35","author":"Habal","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"R15-20260811","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/0960327114550882","article-title":"Pregnancy outcomes in women with inflammatory bowel disease following exposure to thiopurines and antitumor necrosis factor drugs: a systematic review with meta-analysis.","volume":"34","author":"Mozaffari","year":"2015","journal-title":"Hum Exp Toxicol"},{"key":"R16-20260811","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.","volume":"65","author":"de Lima","year":"2016","journal-title":"Gut"},{"key":"R17-20260811","doi-asserted-by":"crossref","first-page":"426","DOI":"10.23922\/jarc.2021-021","article-title":"Safety prediction of infants born to mothers with Crohn\u2019s disease treated with biological agents in the late gestation period.","volume":"5","author":"Sako","year":"2021","journal-title":"J Anus Rectum Colon"},{"key":"R18-20260811","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1093\/ecco-jcc\/jjac086","article-title":"Safety of ustekinumab and vedolizumab during pregnancy-pregnancy, neonatal, and infant outcome: a prospective multicentre study.","volume":"16","author":"Mitrova","year":"2022","journal-title":"J Crohns Colitis"},{"key":"R20-20260811","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2006.00602.x","article-title":"Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease.","volume":"101","author":"Riis","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R21-20260811","doi-asserted-by":"crossref","first-page":"3274","DOI":"10.1111\/j.1572-0241.1999.01537.x","article-title":"Perianal Crohn\u2019s disease and pregnancy: role of the mode of delivery.","volume":"94","author":"Ilnyckyji","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R22-20260811","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s10350-004-0569-0","article-title":"Pregnancy and delivery before and after ileal pouch-anal anastomosis for inflammatory bowel disease: immediate and long-term consequences and outcomes.","volume":"47","author":"Hahnloser","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"R23-20260811","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease.","volume":"9","author":"van der Woude","year":"2015","journal-title":"J Crohns Colitis"},{"key":"R24-20260811","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3390\/nu14081591","article-title":"Inflammatory bowel disease and reproductive health: from fertility to pregnancy-a narrative review.","volume":"14","author":"Ronchetti","year":"2022","journal-title":"Nutrients"},{"key":"R25-20260811","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ibd\/izac185","article-title":"Peripartum infections among women with inflammatory bowel disease.","volume":"29","author":"Narkis","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"R26-20260811","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2011.1692","article-title":"Initiation of tumor necrosis factor-\u03b1 antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.","volume":"306","author":"Grijalva","year":"2011","journal-title":"JAMA"},{"key":"R27-20260811","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","article-title":"Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis.","volume":"14","author":"Bonovas","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R28-20260811","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1053\/j.gastro.2021.04.023","article-title":"AGA technical review on the medical management of moderate to severe luminal and perianal fistulizing Crohn\u2019s disease.","volume":"160","author":"Singh","year":"2021","journal-title":"Gastroenterology"},{"key":"R29-20260811","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/ibd\/izaa236","article-title":"Safety of ustekinumab in inflammatory bowel disease: pooled safety analysis of results from phase 2\/3 studies.","volume":"27","author":"Sandborn","year":"2021","journal-title":"Inflamm Bowel Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T08:03:18Z","timestamp":1786435398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000036253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,1]]},"references-count":28,"journal-issue":{"issue":"48","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036253","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,1]]}}}